vs

Side-by-side financial comparison of NovoCure Ltd (NVCR) and RENASANT CORP (RNST). Click either name above to swap in a different company.

RENASANT CORP is the larger business by last-quarter revenue ($273.8M vs $174.3M, roughly 1.6× NovoCure Ltd). RENASANT CORP runs the higher net margin — 32.2% vs -14.1%, a 46.3% gap on every dollar of revenue. Over the past eight quarters, RENASANT CORP's revenue compounded faster (29.3% CAGR vs 12.2%).

NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.

Renasant Bank is an American regional commercial financial institution based in Tupelo, Mississippi. The bank has more than 280 branches in Alabama, Florida, Georgia, Mississippi, Louisiana, Tennessee, North Carolina and South Carolina. Renasant Bank operates under the parent company Renasant Corporation and is affiliated with Renasant Nation, a platform through which they publish blogs and shows.

NVCR vs RNST — Head-to-Head

Bigger by revenue
RNST
RNST
1.6× larger
RNST
$273.8M
$174.3M
NVCR
Higher net margin
RNST
RNST
46.3% more per $
RNST
32.2%
-14.1%
NVCR
Faster 2-yr revenue CAGR
RNST
RNST
Annualised
RNST
29.3%
12.2%
NVCR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NVCR
NVCR
RNST
RNST
Revenue
$174.3M
$273.8M
Net Profit
$-24.5M
$88.2M
Gross Margin
75.8%
Operating Margin
-23.2%
Net Margin
-14.1%
32.2%
Revenue YoY
8.1%
Net Profit YoY
62.8%
112.5%
EPS (diluted)
$-0.22
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVCR
NVCR
RNST
RNST
Q1 26
$273.8M
Q4 25
$174.3M
$278.4M
Q3 25
$167.2M
$269.5M
Q2 25
$158.8M
$267.2M
Q1 25
$155.0M
$170.7M
Q4 24
$161.3M
$167.1M
Q3 24
$155.1M
$220.3M
Q2 24
$150.4M
$163.8M
Net Profit
NVCR
NVCR
RNST
RNST
Q1 26
$88.2M
Q4 25
$-24.5M
$78.9M
Q3 25
$-37.3M
$59.8M
Q2 25
$-40.1M
$1.0M
Q1 25
$-34.3M
$41.5M
Q4 24
$-65.9M
$44.7M
Q3 24
$-30.6M
$72.5M
Q2 24
$-33.4M
$38.8M
Gross Margin
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
75.8%
Q3 25
73.2%
Q2 25
73.9%
Q1 25
75.1%
Q4 24
79.2%
Q3 24
77.2%
Q2 24
77.0%
Operating Margin
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
-23.2%
34.8%
Q3 25
-21.5%
27.9%
Q2 25
-24.9%
1.0%
Q1 25
-24.4%
30.4%
Q4 24
-39.3%
29.8%
Q3 24
-20.7%
44.2%
Q2 24
-22.3%
29.6%
Net Margin
NVCR
NVCR
RNST
RNST
Q1 26
32.2%
Q4 25
-14.1%
28.4%
Q3 25
-22.3%
22.2%
Q2 25
-25.3%
0.4%
Q1 25
-22.1%
24.3%
Q4 24
-40.9%
26.8%
Q3 24
-19.7%
32.9%
Q2 24
-22.2%
23.7%
EPS (diluted)
NVCR
NVCR
RNST
RNST
Q1 26
$0.94
Q4 25
$-0.22
$0.78
Q3 25
$-0.33
$0.63
Q2 25
$-0.36
$0.01
Q1 25
$-0.31
$0.65
Q4 24
$-0.61
$0.70
Q3 24
$-0.28
$1.18
Q2 24
$-0.31
$0.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVCR
NVCR
RNST
RNST
Cash + ST InvestmentsLiquidity on hand
$93.5M
$1.2B
Total DebtLower is stronger
$806.2M
Stockholders' EquityBook value
$340.5M
$3.9B
Total Assets
$804.3M
$27.1B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVCR
NVCR
RNST
RNST
Q1 26
$1.2B
Q4 25
$93.5M
$1.1B
Q3 25
$342.1M
$1.1B
Q2 25
$149.6M
$1.4B
Q1 25
$127.3M
$1.1B
Q4 24
$163.8M
$1.1B
Q3 24
$185.4M
$1.3B
Q2 24
$164.8M
$851.9M
Total Debt
NVCR
NVCR
RNST
RNST
Q1 26
$806.2M
Q4 25
$499.8M
Q3 25
$558.9M
Q2 25
$557.0M
Q1 25
$433.3M
Q4 24
$430.6M
Q3 24
$433.2M
Q2 24
$428.7M
Stockholders' Equity
NVCR
NVCR
RNST
RNST
Q1 26
$3.9B
Q4 25
$340.5M
$3.9B
Q3 25
$341.3M
$3.8B
Q2 25
$349.4M
$3.8B
Q1 25
$362.0M
$2.7B
Q4 24
$360.2M
$2.7B
Q3 24
$360.8M
$2.7B
Q2 24
$361.8M
$2.4B
Total Assets
NVCR
NVCR
RNST
RNST
Q1 26
$27.1B
Q4 25
$804.3M
$26.8B
Q3 25
$1.4B
$26.7B
Q2 25
$1.2B
$26.6B
Q1 25
$1.2B
$18.3B
Q4 24
$1.2B
$18.0B
Q3 24
$1.2B
$18.0B
Q2 24
$1.2B
$17.5B
Debt / Equity
NVCR
NVCR
RNST
RNST
Q1 26
0.21×
Q4 25
0.13×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.16×
Q3 24
0.16×
Q2 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVCR
NVCR
RNST
RNST
Operating Cash FlowLast quarter
$-18.0M
Free Cash FlowOCF − Capex
$-22.9M
FCF MarginFCF / Revenue
-13.1%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
$-18.0M
$271.5M
Q3 25
$20.6M
$135.5M
Q2 25
$-15.9M
$-77.3M
Q1 25
$-35.7M
$106.2M
Q4 24
$-3.5M
$106.4M
Q3 24
$10.4M
$-1.7M
Q2 24
$-1.7M
$-49.1M
Free Cash Flow
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
$-22.9M
$237.8M
Q3 25
$14.9M
$120.1M
Q2 25
$-21.4M
$-87.5M
Q1 25
$-46.3M
$101.3M
Q4 24
$-12.4M
$92.8M
Q3 24
$-307.0K
$-5.3M
Q2 24
$-13.2M
$-52.6M
FCF Margin
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
-13.1%
85.4%
Q3 25
8.9%
44.6%
Q2 25
-13.5%
-32.7%
Q1 25
-29.9%
59.4%
Q4 24
-7.7%
55.5%
Q3 24
-0.2%
-2.4%
Q2 24
-8.8%
-32.1%
Capex Intensity
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
2.8%
12.1%
Q3 25
3.4%
5.7%
Q2 25
3.5%
3.8%
Q1 25
6.8%
2.8%
Q4 24
5.5%
8.2%
Q3 24
6.9%
1.6%
Q2 24
7.6%
2.1%
Cash Conversion
NVCR
NVCR
RNST
RNST
Q1 26
Q4 25
3.44×
Q3 25
2.27×
Q2 25
-75.92×
Q1 25
2.56×
Q4 24
2.38×
Q3 24
-0.02×
Q2 24
-1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NVCR
NVCR

Segment breakdown not available.

RNST
RNST

Net Interest Income$223.6M82%
Noninterest Income$50.3M18%

Related Comparisons